Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Knapp

Showing results (101-110 of 686) with videos related to

Pageof 69
Sort By:
International Journal of Geriatric Psychiatry|September 11, 1998
The economic consequences of Alzheimer's disease in the context of new drug developmentsM Knapp, D Wilkinson, R Wigglesworth
International Clinical Psychopharmacology|May 1, 2002
Depot antipsychotic preparations in schizophrenia: the state of the economic evidenceM Knapp, S Ilson, A David
The Pennsylvania Nurse|November 1, 1986
IRRC approves long-term care regulationsD Koval, M Knapp, M Alexander
The Journal of Investigative Dermatology|September 1, 1987
Changes in keratinocyte maturation during wound healingJ N Mansbridge, A M Knapp
Klinische Padiatrie|January 1, 1992
[Reference values for the concentration of free triiodothyronine (FT3), triiodothyronine (TT3), free thyroxine (FT4), thyroxine (TT4), thyrotropin (TSH) and thyroxine-binding globulin (TBG) in umbilical cord blood. Method: luminescence-enhanced enzyme immunoassay]N Liappis, H Schlebusch, M Knapp
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|July 7, 2018
Non-ischemic heart preconditioningB Wojcik, M Knapp, J Gorski
The Journal of the Arkansas Medical Society|December 11, 1997
The approach to treatment of invasive pneumococcal disease in the 1990sK M Knapp, G E Schutze
Postgraduate Medical Journal|April 16, 1998
Arterial re-bleed following tPA administrationC M Knapp, J E Pohl
Journal of Trauma Nursing : the Official Journal of the Society of Trauma Nurses|January 8, 2026
Improving Massive Transfusion Protocol Response in the Rural Level III Trauma Center SettingMackenzie B Korsch, Ginger M Knapp
Expert Opinion on Drug Delivery|September 23, 2014
In pursuit of a moving target: nanotherapeutics for the treatment of non-Hodgkin B-cell lymphomaChristopher M Knapp, Kathryn A Whitehead
Pageof 69

Showing results (101-110 of 686) with videos related to

Sort By:
Pageof 69
International Journal of Geriatric Psychiatry|September 11, 1998
The economic consequences of Alzheimer's disease in the context of new drug developmentsM Knapp, D Wilkinson, R Wigglesworth
International Clinical Psychopharmacology|May 1, 2002
Depot antipsychotic preparations in schizophrenia: the state of the economic evidenceM Knapp, S Ilson, A David
The Pennsylvania Nurse|November 1, 1986
IRRC approves long-term care regulationsD Koval, M Knapp, M Alexander
The Journal of Investigative Dermatology|September 1, 1987
Changes in keratinocyte maturation during wound healingJ N Mansbridge, A M Knapp
Klinische Padiatrie|January 1, 1992
[Reference values for the concentration of free triiodothyronine (FT3), triiodothyronine (TT3), free thyroxine (FT4), thyroxine (TT4), thyrotropin (TSH) and thyroxine-binding globulin (TBG) in umbilical cord blood. Method: luminescence-enhanced enzyme immunoassay]N Liappis, H Schlebusch, M Knapp
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|July 7, 2018
Non-ischemic heart preconditioningB Wojcik, M Knapp, J Gorski
The Journal of the Arkansas Medical Society|December 11, 1997
The approach to treatment of invasive pneumococcal disease in the 1990sK M Knapp, G E Schutze
Postgraduate Medical Journal|April 16, 1998
Arterial re-bleed following tPA administrationC M Knapp, J E Pohl
Journal of Trauma Nursing : the Official Journal of the Society of Trauma Nurses|January 8, 2026
Improving Massive Transfusion Protocol Response in the Rural Level III Trauma Center SettingMackenzie B Korsch, Ginger M Knapp
Expert Opinion on Drug Delivery|September 23, 2014
In pursuit of a moving target: nanotherapeutics for the treatment of non-Hodgkin B-cell lymphomaChristopher M Knapp, Kathryn A Whitehead
Pageof 69